Trials / Completed
CompletedNCT05244694
Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to determine if hyperinsulinemia attenuates sympathetic nervous system-mediated vasoconstriction in the human leg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin | Priming dose then a constant infusion at 40 mU•m-2•min-1 |
Timeline
- Start date
- 2020-08-06
- Primary completion
- 2021-06-25
- Completion
- 2021-06-25
- First posted
- 2022-02-17
- Last updated
- 2023-02-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05244694. Inclusion in this directory is not an endorsement.